On 2023-11-20, Acer Therapeutics Inc. (ACER) announced earnings per share of $-0.53 for the fiscal quarter ending 2023-09-30, missing the average analyst estimate of $-0.13.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2023-11-20 | 2023-09-30 | $-0.13 | $-0.53 |
| 2023-08-14 | 2023-06-30 | $-0.26 | $-0.23 |
| 2023-05-15 | 2023-03-31 | $-0.29 | $1.08 |
| 2023-03-27 | 2022-12-31 | $-0.35 | $-0.32 |
| 2022-11-14 | 2022-09-30 | $-0.76 | $-0.31 |
| 2022-08-15 | 2022-06-30 | $-0.58 | $-0.48 |
| 2022-05-16 | 2022-03-31 | $-0.18 | $-0.49 |
| 2022-03-02 | 2021-12-31 | $-0.08 | $-0.31 |
| 2021-11-19 | 2021-09-30 | $-0.28 | $-0.23 |
| 2021-08-10 | 2021-06-30 | $-0.36 | $-0.23 |
| 2021-05-17 | 2021-03-31 | $-0.41 | $-0.11 |
| 2021-03-01 | 2020-12-31 | $-0.43 | $-0.50 |
| 2020-11-10 | 2020-09-30 | $-0.44 | $-0.51 |
| 2020-08-13 | 2020-06-30 | $-0.38 | $-0.56 |
| 2020-05-14 | 2020-03-31 | $-0.40 | $-0.49 |
| 2020-03-18 | 2019-12-31 | $-0.55 | $-0.51 |
| 2019-11-13 | 2019-09-30 | $-0.55 | $-0.52 |
| 2019-08-13 | 2019-06-30 | $-0.81 | $-1.09 |
| 2019-05-14 | 2019-03-31 | $-0.87 | $-0.79 |
| 2019-03-07 | 2018-12-31 | $-0.45 | $-0.85 |
| 2018-11-09 | 2018-09-30 | $-0.53 | $-0.43 |
| 2018-08-13 | 2018-06-30 | $-0.54 | $-0.64 |
| 2018-05-14 | 2018-03-31 | $-0.69 | $-0.53 |
| 2018-03-07 | 2017-12-31 | $-0.56 | $-0.63 |
| 2017-11-13 | 2017-09-30 | -- | $-1.09 |
| 2017-08-14 | 2017-06-30 | -- | $-0.93 |
| 2017-05-12 | 2017-03-31 | -- | $-1.24 |
| 2017-03-28 | 2016-12-31 | -- | $-1.04 |
| 2016-11-14 | 2016-09-30 | -- | $-2.90 |
| 2016-08-11 | 2016-06-30 | $-6.63 | $-3.11 |
| 2016-05-12 | 2016-03-31 | $-6.73 | $-3.21 |
| 2016-03-15 | 2015-12-31 | $-6.21 | $-3.11 |
| 2015-11-10 | 2015-09-30 | $-6.63 | $-4.35 |
| 2015-08-12 | 2015-06-30 | -- | $-5.80 |
| 2015-05-12 | 2015-03-31 | -- | $-9.94 |
| 2015-02-23 | 2014-12-31 | -- | $-9.94 |